As of November 30, 2023, 74 million shares of our common stock were available for future awards under our equity plans, including 14 million shares approved for issuance under our employee stock purchase plan (“ESPP”).

Restricted Stock and Restricted Stock Units (“Restricted Stock Awards”)


Three months ended	November 30, 2023		December 1, 2022

Restricted stock award shares granted	12		14
Weighted-average grant-date fair value per share	$	67.36	$	53.94

Stock-based compensation expense recognized in our statements of operations is presented below. Stock-based compensation expense of $94 million and $88 million was capitalized and remained in inventory as of November 30, 2023 and August 31, 2023, respectively.


Three months ended	November 30, 2023		December 1, 2022

Stock-based compensation expense by caption
Research and development	$	68	$	53
Cost of goods sold	67		36
Selling, general, and administrative	47		37
	$	182	$	126

Stock-based compensation expense by type of award
Restricted stock awards	$	163	$	109
ESPP	19		17
	$	182	$	126

As of November 30, 2023, $1.84 billion of total unrecognized compensation costs for unvested awards, before the effect of any future forfeitures, was expected to be recognized through the first quarter of 2028, resulting in a weighted-average period of 1.4 years.